Cannabis Watch: Cannabis stocks climb after Canopy posts revenue jump and Aphria uncovers conflicts

Cannabis stocks were mostly higher Friday, as investors digested earnings from Canopy Growth Corp. and the news that Aphria Inc.’s probe of acquisitions in Latin America found certain board members had conflicts. The biggest weed company by market value, Canopy CGC, +3.12% WEED, +2.50%  posted a 282% rise in quarterly revenue thanks to Canadian legalization,…

Continue Reading

UK researchers are launching a trial looking at a cannabis-based therapy for Alzheimer’s

A research team at King’s College London is launching a Phase 2 trial of a cannabis-based therapy for the treatment of certain dementia symptoms. The therapy, called Sativex, is a cannabis-based medication currently approved in the United Kingdom for the treatment of muscle stiffness and tightness in patients with multiple sclerosis. Researchers hope it will…

Continue Reading

Your cable company may soon be forced to be more transparent about your bill

Customers dazzled by too-good-to-be-true cable and internet deals could soon get a break. Legislation introduced this month by U.S. Representative Anna Eshoo, a Democrat from California, and Senator Ed Markey, a Democrat from Massachusetts, would require phone, cable and internet providers to include all charges in advertised prices. The ‘‘Truth-in-Billing, Remedies, and User Empowerment over…

Continue Reading